ATNM — Actinium Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $31.06m
- -$11.06m
- $0.09m
Brief: Actinium Pharmaceuticals Announces Proposed Public Offering
Brief: Actinium Provides Update On Iomab-B Sierra Trial And Expected Topline Results From Ad HOC Analysis In 2020
Brief: Actinium Pharmaceuticals Announces First Patient Treated In Third And Final Dose Cohort Of Actimab-A Clag-M Combination Phase 1 Trial In Acute Myeloid Leukemia
Brief: Actinium Pharmaceuticals Says Actimab-A Being Studied In A Phase 1 Combination With Bcl-2 Inhibitor In Patients With Relapsed Or Refractory AML
Brief: Actinium Presents Positive Findings From Mid-Point Analysis Of Pivotal Sierra Trial Of Iomab-B At 2020 Transplantation & Cellular Therapy Meetings Of ASTCT And CIBMTR
Brief: Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration With UC Davis
Brief: Actinium Pharmaceuticals Says ACTIMAB-A CLAG-M Phase 1 Trial Is Expected To Be Completed In Mid-2020
Brief: Actinium Pharmaceuticals Announces Phase 3 Sierra Trial Dosimetry Results
U.S. STOCKS ON THE MOVE-Fitbit, Beyond Meat, Lululemon Athletica, Tiffany, PG&E, Cabot Oil & Gas
Actinium Pharma slips on late-stage cancer drug trial data
Brief: Actinium Announces Positive Interim Results From Iomab-B Pivotal Phase 3 Sierra Trial At 50% Of Total Patient Enrollment
Brief: Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial for Iomab-B
Brief: Actinium Presents New Data Demonstrating Effective Lymphodepletion With Lutetium-177 For Car-T
Brief: Actinium To Present At 2019 Society Of Nuclear Medicine And Molecular Imaging Annual Meeting
Actinium Pharma: Eyes two-month high after positive cancer drug data
Brief: Sabby Management LLC Reports 8.02 Pct Passive Stake In Actinium Pharmaceuticals
Brief: Actinium Pharmaceuticals Announces Pricing Of $16.5 Million Public Offering Of Common Stock And Warrants
Actinium Pharmaceuticals: Falls after pricing equity offering
Brief: Actinium Pharmaceuticals Inc. Announces Proposed Public Offering Of Common Stock And Warrants